257 related articles for article (PubMed ID: 18278426)
41. Molecular mechanism for low pH triggered misfolding of the human prion protein.
DeMarco ML; Daggett V
Biochemistry; 2007 Mar; 46(11):3045-54. PubMed ID: 17315950
[TBL] [Abstract][Full Text] [Related]
42. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
Havsteen BH
J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
[TBL] [Abstract][Full Text] [Related]
43. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
[TBL] [Abstract][Full Text] [Related]
44. Generating antibodies against the native form of the human prion protein (hPrP) in wild-type animals: a comparison between DNA and protein immunizations.
Alexandrenne C; Wijkhuisen A; Dkhissi F; Hanoux V; Créminon C; Boquet D; Couraud JY
J Immunol Methods; 2009 Feb; 341(1-2):41-9. PubMed ID: 19027745
[TBL] [Abstract][Full Text] [Related]
45. Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PrP(Sc).
Gao JM; Zhou XB; Xiao XL; Zhang J; Chen L; Gao C; Zhang BY; Dong XP
Acta Virol; 2006; 50(1):25-32. PubMed ID: 16599182
[TBL] [Abstract][Full Text] [Related]
46. Epitope mapping of a PrP(Sc)-specific monoclonal antibody: identification of a novel C-terminally truncated prion fragment.
Kosmač M; Koren S; Giachin G; Stoilova T; Gennaro R; Legname G; Serbec VČ
Mol Immunol; 2011 Feb; 48(5):746-50. PubMed ID: 21176851
[TBL] [Abstract][Full Text] [Related]
47. In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm.
Yang W; Yang H; Tien P
FEBS Lett; 2006 Jul; 580(17):4231-5. PubMed ID: 16831424
[TBL] [Abstract][Full Text] [Related]
48. Photo-induced crosslinking of prion protein oligomers and prions.
Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
[TBL] [Abstract][Full Text] [Related]
49. Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities.
Rezaei H; Eghiaian F; Perez J; Doublet B; Choiset Y; Haertle T; Grosclaude J
J Mol Biol; 2005 Apr; 347(3):665-79. PubMed ID: 15755458
[TBL] [Abstract][Full Text] [Related]
50. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
51. Pathway complexity of prion protein assembly into amyloid.
Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
[TBL] [Abstract][Full Text] [Related]
52. Consequences of manganese replacement of copper for prion protein function and proteinase resistance.
Brown DR; Hafiz F; Glasssmith LL; Wong BS; Jones IM; Clive C; Haswell SJ
EMBO J; 2000 Mar; 19(6):1180-6. PubMed ID: 10716918
[TBL] [Abstract][Full Text] [Related]
53. Prion protein oligomer and its neurotoxicity.
Huang P; Lian F; Wen Y; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
[TBL] [Abstract][Full Text] [Related]
54. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
55. Structure of infectious prions: stabilization by domain swapping.
Yang S; Levine H; Onuchic JN; Cox DL
FASEB J; 2005 Nov; 19(13):1778-82. PubMed ID: 16260647
[TBL] [Abstract][Full Text] [Related]
56. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
57. Potential of mean force for Syrian hamster prion epitope protein--monoclonal fab 3f4 antibody interaction studies.
Wang YT; Su ZY; Liao JM; Chen CL
Eur J Med Chem; 2009 Sep; 44(9):3504-8. PubMed ID: 19304354
[TBL] [Abstract][Full Text] [Related]
58. Pilot study to determine the feasibility of producing protease-resistant prion protein fragments by random PCR mutagenesis.
Dear DV; Fitzmaurice TJ; Garton S; Richards SJ
Biochem Biophys Res Commun; 2001 Mar; 281(4):929-35. PubMed ID: 11237750
[TBL] [Abstract][Full Text] [Related]
59. Probing structural differences between PrP(C) and PrP(Sc) by surface nitration and acetylation: evidence of conformational change in the C-terminus.
Gong B; Ramos A; Vázquez-Fernández E; Silva CJ; Alonso J; Liu Z; Requena JR
Biochemistry; 2011 Jun; 50(22):4963-72. PubMed ID: 21526750
[TBL] [Abstract][Full Text] [Related]
60. Mapping the prion protein using recombinant antibodies.
Williamson RA; Peretz D; Pinilla C; Ball H; Bastidas RB; Rozenshteyn R; Houghten RA; Prusiner SB; Burton DR
J Virol; 1998 Nov; 72(11):9413-8. PubMed ID: 9765500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
